Doximity (DOCS) Restructuring Costs (2023 - 2024)
Doximity (DOCS) reported Restructuring Costs of $2.3 million for Q3 2024, down 70.84% year-over-year from $7.9 million in Q4 2023, and down 45.89% on a QoQ basis from $4.3 million in Q1 2024.
Doximity (DOCS) has 2 years of Restructuring Costs data on file, last reported at $2.3 million in Q3 2024.
- Quarterly Restructuring Costs fell 70.84% year-over-year to $2.3 million in Q3 2024, while the trailing twelve-month figure through Mar 2025 was $6.6 million (down 46.03% YoY) and the FY2025 annual result came in at $2.3 million, down 70.97% from the prior year.
- Restructuring Costs eased to $2.3 million in Q3 2024 per DOCS's latest filing, from $4.3 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $7.9 million in Q3 2023 and bottomed at $2.3 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Sep 30, 2023 | 7.90 Mn |